According to the latest report published by Data Bridge Market Research, the PPG (Photoplethysmography) Biosensors Market  CAGR Value The PPG (Photoplethysmography) biosensors market size was valued at USD 549.27 million in 2024 and is projected to reach USD 1196.37 million by 2032, with a CAGR of 10.22% during the forecast period of 2025 to 2032.  Market definition...

Polaris Market Research has published its latest research report titled Biosensors Market Share, Size, Trends, Industry Analysis Report By Application (Medical, Food Toxicity), By End-Use, By Region – Market Forecast, 2026–2034. The report examines the global Biosensors Market , covering its current size, market share, growth prospects, and industry developments. It discusses the...

Polaris Market Research announces the release of its latest research report Glucose Biosensor Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve decision-makers...

The global photoplethysmography (PPG) biosensors market was valued at USD 1.8 billion in 2025 and is expected to reach USD 2.0 billion in 2026. The market is projected to expand to USD 5.2 billion by 2033, registering a CAGR of 14.8% from 2026 to 2033. North America dominated the global market in 2025, accounting for approximately 40.0% of total revenue. Meanwhile, Asia Pacific is expected to...

Microfluidics Market: Transforming Precision Diagnostics, Drug Discovery, and Point-of-Care Healthcare Microfluidics Market Snapshot The Microfluidics Market is witnessing remarkable growth as miniaturized fluid-handling technologies revolutionize healthcare diagnostics, life sciences research, pharmaceutical development, and industrial applications. According to M2Square...

The biosensors market was valued at USD 32.2 billion in 2025 and is projected to grow from USD 34.7 billion in 2026 to USD 64.0 billion by 2033, representing a CAGR of 9.1% from 2026 to 2033. The expansion reflects increasing medical applications, the rising prevalence of chronic and non-communicable diseases such as diabetes and hypertension, and continued technological advancements. Download...